Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

21 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
CD4 regulatory T cells in human cancer pathogenesis.
Knutson KL, Disis ML, Salazar LG. Knutson KL, et al. Among authors: salazar lg. Cancer Immunol Immunother. 2007 Mar;56(3):271-85. doi: 10.1007/s00262-006-0194-y. Epub 2006 Jul 4. Cancer Immunol Immunother. 2007. PMID: 16819631 Review.
HER-2/neu vaccine-primed autologous T-cell infusions for the treatment of advanced stage HER-2/neu expressing cancers.
Disis ML, Dang Y, Coveler AL, Marzbani E, Kou ZC, Childs JS, Fintak P, Higgins DM, Reichow J, Waisman J, Salazar LG. Disis ML, et al. Among authors: salazar lg. Cancer Immunol Immunother. 2014 Feb;63(2):101-9. doi: 10.1007/s00262-013-1489-4. Epub 2013 Oct 26. Cancer Immunol Immunother. 2014. PMID: 24162107 Free PMC article. Clinical Trial.
Peptide-based vaccines in breast cancer.
Disis ML, Salazar LG, Knutson KL. Disis ML, et al. Among authors: salazar lg. Breast Dis. 2004;20:3-11. doi: 10.3233/bd-2004-20102. Breast Dis. 2004. PMID: 15687702 Review.
HER-2/neu vaccines.
Disis ML, Schiffman K, Salazar LG, Almand B, Knutson KL. Disis ML, et al. Among authors: salazar lg. Cancer Chemother Biol Response Modif. 2003;21:275-85. doi: 10.1016/s0921-4410(03)21013-9. Cancer Chemother Biol Response Modif. 2003. PMID: 15338750 Review. No abstract available.
21 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page